200 related articles for article (PubMed ID: 18455202)
1. Recruitment of beta-arrestin2 to the dopamine D2 receptor: insights into anti-psychotic and anti-parkinsonian drug receptor signaling.
Klewe IV; Nielsen SM; Tarpø L; Urizar E; Dipace C; Javitch JA; Gether U; Egebjerg J; Christensen KV
Neuropharmacology; 2008 Jun; 54(8):1215-22. PubMed ID: 18455202
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics.
Masri B; Salahpour A; Didriksen M; Ghisi V; Beaulieu JM; Gainetdinov RR; Caron MG
Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13656-61. PubMed ID: 18768802
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D
Ferraiolo M; Atik H; Ponthot R; Koener B; Hanson J; Hermans E
Neuropharmacology; 2022 Apr; 207():108942. PubMed ID: 35026287
[TBL] [Abstract][Full Text] [Related]
4. G protein-coupled receptor kinase regulates dopamine D3 receptor signaling by modulating the stability of a receptor-filamin-beta-arrestin complex. A case of autoreceptor regulation.
Kim KM; Gainetdinov RR; Laporte SA; Caron MG; Barak LS
J Biol Chem; 2005 Apr; 280(13):12774-80. PubMed ID: 15687500
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotics differ in their ability to internalise human dopamine D2S and human serotonin 5-HT1A receptors in HEK293 cells.
Heusler P; Newman-Tancredi A; Loock T; Cussac D
Eur J Pharmacol; 2008 Feb; 581(1-2):37-46. PubMed ID: 18190908
[TBL] [Abstract][Full Text] [Related]
6. On the existence of a possible A2A-D2-β-Arrestin2 complex: A2A agonist modulation of D2 agonist-induced β-arrestin2 recruitment.
Borroto-Escuela DO; Romero-Fernandez W; Tarakanov AO; Ciruela F; Agnati LF; Fuxe K
J Mol Biol; 2011 Mar; 406(5):687-99. PubMed ID: 21256133
[TBL] [Abstract][Full Text] [Related]
7. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
[TBL] [Abstract][Full Text] [Related]
8. The role of beta-arrestin2 in shaping fMRI BOLD responses to dopaminergic stimulation.
Sahlholm K; Ielacqua GD; Xu J; Jones LA; Schlegel F; Mach RH; Rudin M; Schroeter A
Psychopharmacology (Berl); 2017 Jul; 234(13):2019-2030. PubMed ID: 28382543
[TBL] [Abstract][Full Text] [Related]
9. BRET approaches to characterize dopamine and TAAR1 receptor pharmacology and signaling.
Espinoza S; Masri B; Salahpour A; Gainetdinov RR
Methods Mol Biol; 2013; 964():107-22. PubMed ID: 23296781
[TBL] [Abstract][Full Text] [Related]
10. Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy.
Allen JA; Yost JM; Setola V; Chen X; Sassano MF; Chen M; Peterson S; Yadav PN; Huang XP; Feng B; Jensen NH; Che X; Bai X; Frye SV; Wetsel WC; Caron MG; Javitch JA; Roth BL; Jin J
Proc Natl Acad Sci U S A; 2011 Nov; 108(45):18488-93. PubMed ID: 22025698
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling.
Jordan S; Johnson JL; Regardie K; Chen R; Koprivica V; Tadori Y; Kambayashi J; Kitagawa H; Kikuchi T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):348-56. PubMed ID: 17070976
[TBL] [Abstract][Full Text] [Related]
12. Effects of recent and reference antipsychotic agents at human dopamine D2 and D3 receptor signaling in Chinese hamster ovary cells.
Vanhauwe JF; Ercken M; van de Wiel D; Jurzak M; Leysen JE
Psychopharmacology (Berl); 2000 Jul; 150(4):383-90. PubMed ID: 10958079
[TBL] [Abstract][Full Text] [Related]
13. Discovery and characterization of a G protein-biased agonist that inhibits β-arrestin recruitment to the D2 dopamine receptor.
Free RB; Chun LS; Moritz AE; Miller BN; Doyle TB; Conroy JL; Padron A; Meade JA; Xiao J; Hu X; Dulcey AE; Han Y; Duan L; Titus S; Bryant-Genevier M; Barnaeva E; Ferrer M; Javitch JA; Beuming T; Shi L; Southall NT; Marugan JJ; Sibley DR
Mol Pharmacol; 2014 Jul; 86(1):96-105. PubMed ID: 24755247
[TBL] [Abstract][Full Text] [Related]
14. RGS2 modulates the activity and internalization of dopamine D2 receptors in neuroblastoma N2A cells.
Luessen DJ; Hinshaw TP; Sun H; Howlett AC; Marrs G; McCool BA; Chen R
Neuropharmacology; 2016 Nov; 110(Pt A):297-307. PubMed ID: 27528587
[TBL] [Abstract][Full Text] [Related]
15. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptor.
Newman-Tancredi A; Cussac D; Audinot V; Nicolas JP; De Ceuninck F; Boutin JA; Millan MJ
J Pharmacol Exp Ther; 2002 Nov; 303(2):805-14. PubMed ID: 12388667
[TBL] [Abstract][Full Text] [Related]
16. Novel roles for β-arrestins in the regulation of pharmacological sequestration to predict agonist-induced desensitization of dopamine D3 receptors.
Min C; Zheng M; Zhang X; Caron MG; Kim KM
Br J Pharmacol; 2013 Nov; 170(5):1112-29. PubMed ID: 23992580
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D2 and angiotensin II type 1 receptors form functional heteromers in rat striatum.
Martínez-Pinilla E; Rodríguez-Pérez AI; Navarro G; Aguinaga D; Moreno E; Lanciego JL; Labandeira-García JL; Franco R
Biochem Pharmacol; 2015 Jul; 96(2):131-42. PubMed ID: 25986885
[TBL] [Abstract][Full Text] [Related]
18. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
[TBL] [Abstract][Full Text] [Related]
19. Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors.
Perachon S; Schwartz JC; Sokoloff P
Eur J Pharmacol; 1999 Feb; 366(2-3):293-300. PubMed ID: 10082211
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of Dopamine Receptor 2 Long Affects Cannabinoid Receptor 1 Signaling in a Cell Culture Model of Striatal Medium Spiny Projection Neurons.
Bagher AM; Laprairie RB; Kelly ME; Denovan-Wright EM
Mol Pharmacol; 2016 Jun; 89(6):652-66. PubMed ID: 27053685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
